Trials / Conditions / Focal Onset Seizure

Focal Onset Seizure

8 registered clinical trials studyying Focal Onset Seizure — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures NCT07219407	Rapport Therapeutics Inc.	Phase 2
Recruiting	An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic NCT06908356	Praxis Precision Medicines	Phase 2
Active Not Recruiting	Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset E NCT06453213	SK Life Science, Inc.	Phase 4
Completed	This is a Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in Patients Suffering From Epil NCT05747001	Aziende Chimiche Riunite Angelini Francesco S.p.A	—
Active Not Recruiting	Cenobamate in Adults With Focal-Onset Seizures NCT05859854	Aziende Chimiche Riunite Angelini Francesco S.p.A	—
Terminated	Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications NCT05493293	Neurocrine Biosciences	Phase 2
Completed	A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Me NCT05159908	Neurocrine Biosciences	Phase 2
Unknown	A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy NCT04737837	Jiangxi Qingfeng Pharmaceutical Co. Ltd.	—